These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30628950)

  • 1. Comparison Between Continuous and Intermittent Administration of Hydrocortisone During Septic Shock: A Randomized Controlled Clinical Trial.
    Tilouche N; Jaoued O; Ali HBS; Gharbi R; Fekih Hassen M; Elatrous S
    Shock; 2019 Nov; 52(5):481-486. PubMed ID: 30628950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Hydrocortisone Continuous Infusion Versus Intermittent Boluses in Resolution of Septic Shock.
    Hoang H; Wang S; Islam S; Hanna A; Axelrad A; Brathwaite C
    P T; 2017 Apr; 42(4):252-255. PubMed ID: 28381918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.
    Loisa P; Parviainen I; Tenhunen J; Hovilehto S; Ruokonen E
    Crit Care; 2007; 11(1):R21. PubMed ID: 17306016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Continuous Infusion vs Bolus Dose of Hydrocortisone in Septic Shock: A Prospective Randomized Study.
    Salhotra R; Sharahudeen A; Tyagi A; Rautela RS; Kemprai R
    Indian J Crit Care Med; 2024 Sep; 28(9):837-841. PubMed ID: 39360201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial.
    Ram GK; Shekhar S; Singh RB; Anand R; De RR; Kumar N
    Anesth Essays Res; 2022; 16(3):321-325. PubMed ID: 36620116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
    ; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
    JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
    Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
    JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses vs Continuous Infusion in Septic Shock: A Retrospective Study.
    Mitwally H; Saad MO; Mahmoud S; Mohamed A
    Indian J Crit Care Med; 2021 Jan; 25(1):29-33. PubMed ID: 33603298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions.
    Kaufmann I; Briegel J; Schliephake F; Hoelzl A; Chouker A; Hummel T; Schelling G; Thiel M
    Intensive Care Med; 2008 Feb; 34(2):344-9. PubMed ID: 17906853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing, method and discontinuation of hydrocortisone administration for septic shock patients.
    Ibarra-Estrada MA; Chávez-Peña Q; Reynoso-Estrella CI; Rios-Zermeño J; Aguilera-González PE; García-Soto MA; Aguirre-Avalos G
    World J Crit Care Med; 2017 Feb; 6(1):65-73. PubMed ID: 28224109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
    Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
    JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
    Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
    Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
    Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
    JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients.
    Weber-Carstens S; Deja M; Bercker S; Dimroth A; Ahlers O; Kaisers U; Keh D
    Intensive Care Med; 2007 Apr; 33(4):730-3. PubMed ID: 17325831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone as Adjunctive Therapy in Septic Shock: A Retrospective Cohort Study.
    Lock AE; Gutierrez GC; Hand EO; Barthol CA; Attridge RL
    Ann Pharmacother; 2023 Dec; 57(12):1375-1388. PubMed ID: 37026172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Increasing Hydrocortisone to 300 mg Per Day in the Treatment of Septic Shock: a Pilot Study.
    Hyvernat H; Barel R; Gentilhomme A; Césari-Giordani JF; Freche A; Kaidomar M; Goubaux B; Pradier C; Dellamonica J; Bernardin G
    Shock; 2016 Nov; 46(5):498-505. PubMed ID: 27405061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of the use of hydrocortisone for treatment of suspected critical illness-related corticosteroid insufficiency (CIRCI) in dogs with septic shock (2010-2017): 47 cases.
    Summers AM; Culler C; Yaxley PE; Guillaumin J
    J Vet Emerg Crit Care (San Antonio); 2021 May; 31(3):371-379. PubMed ID: 33599090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of late septic shock with supraphysiologic doses of hydrocortisone.
    Bollaert PE; Charpentier C; Levy B; Debouverie M; Audibert G; Larcan A
    Crit Care Med; 1998 Apr; 26(4):645-50. PubMed ID: 9559600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.